Novel compounds are evaluated through a combination of in vitro and in vivo studies, along with advanced computational modeling. In vitro methods help identify potential cytotoxicity and genotoxicity, while in vivo studies provide insights into systemic effects. Computational models can predict potential toxicity based on the structure-activity relationship (SAR).
